ListedSMEPharmaceuticals & DrugsCURIS
Curis Lifesciences IPO
Curis Lifesciences IPO is a sme IPO raising ₹27 Cr at ₹120 – ₹128 a share. It listed on 14 Nov 2025 and trades at ₹112 today, −12.5% against its issue price of ₹128. It was subscribed 0.00× in total.
₹128
Issue price
₹112
Price now
−12.5%
Since issue price
14 Nov 2025
Listed on
0.00×Subscribed (final) · all exchanges
No bids yet
populated partly populated we hold nothing here — the tab says why
Who bid for it
| Investor category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| QIB Banks, funds and other large institutions | 0 | 3,93,35,000 | 0.00× |
| Foreign Institutional Investors | no separate quota | 1,46,31,000 | n/a |
| Domestic Financial Institutions | no separate quota | 8,08,000 | n/a |
| Mutual funds | no separate quota | 0 | n/a |
| Others | no separate quota | 2,38,96,000 | n/a |
| Non-institutional Wealthy individuals and companies bidding above ₹2 lakh | 0 | 3,56,71,000 | 0.00× |
| Non Institutional Investors | 0 | 2,95,12,000 | 0.00× |
| Corporates | no separate quota | 9,80,000 | n/a |
| Individuals | no separate quota | 2,80,20,000 | n/a |
| Others | no separate quota | 5,12,000 | n/a |
| Non Institutional Investors | 0 | 61,59,000 | 0.00× |
| Corporates | no separate quota | 1,98,000 | n/a |
| Individuals | no separate quota | 58,32,000 | n/a |
| Others | no separate quota | 1,29,000 | n/a |
| Total | 0 | 7,50,06,000 | 0.00× |
Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 06:06 pm IST.
How demand built
Only one reading so far. We sample subscription every hour and store it whenever it moves, so this becomes a curve as bidding runs.